Johnson & Johnson Private Limited
Clinical trials sponsored by Johnson & Johnson Private Limited, explained in plain language.
-
New drug teclistamab tested for safety in Tough-to-Treat blood cancer
Disease control Recruiting nowThis study tests the safety of teclistamab, a drug given as a shot, in 75 Indian adults with multiple myeloma that has come back or not responded to at least three prior treatments. The goal is to see how safe it is in routine practice. Participants must have tried specific prior…
Phase: PHASE4 • Sponsor: Johnson & Johnson Private Limited • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New hope for indian patients with psoriatic arthritis: guselkumab trial launches
Disease control Recruiting nowThis study tests a drug called guselkumab in 100 Indian adults with psoriatic arthritis, a condition causing joint pain and swelling. Participants must have tried standard treatments without success. The goal is to see if the drug is safe and helps reduce joint symptoms over 12 w…
Phase: PHASE4 • Sponsor: Johnson & Johnson Private Limited • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC